Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for technology industry professionals · Wednesday, January 8, 2025 · 775,022,413 Articles · 3+ Million Readers

Shelby Group Enterprises LLC. Closes Share Purchase with Perpetua Medical,AB of Uppsala Sweden for Pharmacolog USA, Inc.

Pharmacolog logo

WasteLog™ Device

WasteLog™ Device

Pharmacolog Dashboard™ for reporting and Remote Expert Guidance

Pharmacolog Dashboard™ for reporting and Remote Expert Guidance

Shelby Group Enterprises, LLC. acquires Pharmacolog USA, Inc. from Swedish based Perpetua Medical AB.

Pharmacolog will continue its commitment to Medication Safety and Efficacy with enhancements to existing products and development of new ones”
— Steve Maiorano, CEO
CHERRY VALLEY, NY, UNITED STATES, January 6, 2025 /EINPresswire.com/ -- Shelby Group Enterprises, LLC. has announced the successful closure of a share purchase agreement with Perpetua Medical AB of Uppsala Sweden for the acquisition of Pharmacolog USA, Inc. This deal, which was finalized on December 6th, 2024, marks the first part of a two-part agreement between the two companies.

The President of Shelby Group Enterprises, LLC. and former Director at Pharmacolog USA, Inc., Steve Maiorano will take on the role of CEO for the organization. Maiorano brings with him a wealth of experience and expertise in the medication safety & diversion prevention industry, making him a valuable leader for Pharmacolog USA, Inc.

Steve Maiorano comments:
"I am thrilled to have closed this deal with Perpetua Medical and are excited to strengthen Pharmacolog' s position in the market. Pharmacolog will continue its commitment to Medication Safety and Efficacy with enhancements to existing products and development of new ones. I'm excited to be leading the organization into the next phases of combating the diversion of dangerous controlled substances" 

The acquisition of Pharmacolog USA, Inc. is a strategic move and is expected to bring about numerous opportunities for growth and development. The company looks forward to leveraging new partnerships to further strengthen its position in the market.  Pharmacolog USA, Inc. will remain headquartered in Chicago, IL with a Seattleite office in New York.

Pharmacolog USA, Inc. manufactures and markets WasteLog™ for the analysis and verification of injectable controlled substance waste in Healthcare settings. WasteLog™ enhances existing Drug Diversion Prevention Programs by deterring and detecting potential diversion of dangerous controlled substances. Pharmacolog USA, Inc. has established itself as a leader in the field with the use of UV-VIS spectroscopy and proprietary software.

For more information about Pharmacolog USA, Inc. please contact their media relations team at Info@pharmacolog.com

###

Stephen Maiorano
Pharmacolog USA, Inc.
+1 866-768-7766
email us here
Visit us on social media:
LinkedIn

Powered by EIN Presswire

Distribution channels: Emergency Services, Healthcare & Pharmaceuticals Industry, Technology

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Submit your press release